About Avalon GloboCare Corp. - Common Stock (ALBT)
Avalon GloboCare Corp. is a healthcare innovation company focused on advanced cell-based technologies and the development of transformative treatment solutions. The firm specializes in the research, design, and commercialization of cell therapies, with a particular emphasis on addressing unmet medical needs in areas such as cancer, immunology, and regenerative medicine. By leveraging its proprietary platforms and strategic partnerships, Avalon aims to drive the next generation of cellular medicine, improving patient outcomes and enhancing the efficacy of therapies. Through its integrated approach, the company is committed to advancing the frontiers of healthcare and making a meaningful impact on global health challenges. Read More
Avalon GloboCare Corp. (Nasdaq: ALBT ) is a technology-focused company developing and acquiring innovative artificial intelligence platforms. Through its AI-driven subsidiary, Avalon Quantum AI LLC, ALBT is advancing next-generation AI systems, including automated video generation, enterprise documentation, and workflow automation solutions. ALBT is also expanding its intellectual property portfolio in cellular therapy and generative AI publishing and software.
Avalon GloboCare Corp. (NASDAQ: ALBT), ENDRA Life Sciences Inc. (NASDAQ: NDRA) , Curanex Pharmaceuticals Inc. (NASDAQ: CURX) , and Healthcare Triangle, Inc. (NASDAQ: HCTI) are capturing market attention with strategic technology integrations, clinical validation progress, regulatory manufacturing milestones, and global digital health expansion, driving heightened search activity for AI healthcare equities, biotech pipelines, and short squeeze catalysts.
FREEHOLD, NJ — On January 12, 2026, Avalon GloboCare Corp. (NASDAQ: ALBT) officially announced that it has regained compliance with Nasdaq’s minimum stockholders' equity requirement, effectively ending a months-long threat of delisting from the Nasdaq Capital Market. The company, which had been struggling with a multi-million dollar equity deficit throughout
Myseum, Inc. (Nasdaq: MYSE) a leader in digital privacy and next-generation social media technology, today announced the successful completion of the sale of its approximately 35% minority ownership interest in RPM Interactive, Inc. (“RPM”), following Avalon GloboCare Corp.’s (Nasdaq: ALBT ) agreement to acquire 100% of RPM .
Avalon GloboCare Corp. (NASDAQ: ALBT) acquired RPM Interactive, Inc. to expand digital marketing capabilities and strengthen balance sheet. Deal valued at $19.5M and includes AI technology for branded content creation.
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
NEW YORK, May 03, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
